Today’s Research Reports on Trending Tickers: Synergy Pharmaceuticals and Mylan N.V.

NEW YORK, NY / ACCESSWIRE / June 6, 2018 / Major indexes closed mostly higher Tuesday, lifted by a rally from the technology sector. The Dow Jones Industrial Average decreased 0.06 percent to close at 24,799.98, weighed by losses from consumer-staples and financial sectors, while the S&P 500 Index climbed 0.07 percent to close at 2,748.80. The Nasdaq Composite Index was up 0.41 percent to close at 7,637.86.

“Our view is that the current economic expansion and bull market has room to run and we aren’t looking at the prospect of a recession starting until 2020 at the earliest,” said Albert Brenner, director of asset allocation strategy at People’s United Advisors.

RDI Initiates Coverage on:

Synergy Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=SGYP

Mylan N.V.
https://rdinvesting.com/news/?ticker=MYL

Synergy Pharmaceuticals’ stock jumped 7.59% Tuesday, to close the day at $1.70. The stock recorded a trading volume of 3,283,540 shares, which was below its three months average volume of 3,433,587 shares. In the last year, Synergy Pharmaceuticals’ shares have traded in a range of 1.43 – 4.84. The share price has gained 18.88% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $1.65 is below its 200-day moving average of $1.95. Shares of Synergy Pharmaceuticals have gained roughly 4.94 percent in the past month and are down 23.77 percent year-to-date.

Access RDI’s Synergy Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SGYP

On Tuesday, shares of Mylan recorded a trading volume of 12,382,292 shares, which was above the three months average volume of 4,429,581 shares. The stock ended the day 3.84% higher at $39.98. The share price has fallen 16.39% from its 52-week high with a 52-week trading range of 29.39 – 47.82. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $38.85 is below its 200-day moving average of $40.75. Shares of the company are trading at a Price to Earnings ratio of 30.75. Shares of Mylan have gained roughly 11.12 percent in the past month and are down 5.51 percent year-to-date.

Access RDI’s Mylan N.V. Research Report at:
https://rdinvesting.com/news/?ticker=MYL

Our Actionable Research on Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) and Mylan N.V. (NASDAQ:MYL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501901